Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Sharma, Arun  [Clear All Filters]
Journal Article
Garcia G, Sharma A, Ramaiah A, Sen C, Purkayastha A, Kohn DB, Parcells MS, Beck S, Kim H, Bakowski MA, et al. Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication. Cell Rep. 2021:108940.
Arzt M, Mozneb M, Escopete S, Moses J, Sharma A. The Benefits of Stem Cell Biology and Tissue Engineering in Low-Earth Orbit. Stem Cells Dev. 2024.
Goedegebuure M, Bury M, Wang X, San Felice P, Cammarata F, Wang L, Sharma T, Rajinikanth N, Karra V, Siddha V, et al. A biodegradable microgrooved and tissue mechanocompatible citrate-based scaffold improves bladder tissue regeneration. bioRxiv. 2024.
Sharma A, Clemens RA, Garcia O, D Taylor L, Wagner NL, Shepard KA, Gupta A, Malany S, Grodzinsky AJ, Kearns-Jonker M, et al. Biomanufacturing in low Earth orbit for regenerative medicine. Stem Cell Reports. 2021.
Arzt M, Pohlman S, Mozneb M, Sharma A. Chemically Defined Production of Tri-Lineage Human iPSC-Derived Cardiac Spheroids. Curr Protoc. 2023;3(5):e767.
Sharma A, Li G, Rajarajan K, Hamaguchi R, Burridge PW, Wu SM. Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation. J Vis Exp. 2015;(97).
Sharma A, Scott CThomas. The ethics of publishing human germline research. Nat Biotechnol. 2015;33(6):590-592.
Sharma A, Zhang Y, Wu SM. Harnessing the Induction of Cardiomyocyte Proliferation for Cardiac Regenerative Medicine. Curr Treat Options Cardiovasc Med. 2015;17(10):404.
Burridge PW, Li YFuga, Matsa E, Wu H, Ong S-G, Sharma A, Holmström A, Chang AC, Coronado MJ, Ebert AD, et al. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med. 2016.
Sharma A, Garcia G, Arumugaswami V, Svendsen CN. Human iPSC-Derived Cardiomyocytes are Susceptible to SARS-CoV-2 Infection. bioRxiv. 2020.
Bonner-Weir S, Guo L, Li W-C, Ouziel-Yahalom L, Weir GC, Sharma A. Islet Neogenesis: A Possible Pathway for Beta-Cell Replenishment. Rev Diabet Stud. 2012;9(4):407-416.
Aguayo-Mazzucato C, Dilenno A, Hollister-Lock J, Cahill C, Sharma A, Weir G, Colton C, Bonner-Weir S. MAFA and T3 drive maturation of both fetal human islets and insulin-producing cells differentiated from hESC. J Clin Endocrinol Metab. 2015:jc20152632.
Satta S, Rockwood SJ, Wang K, Wang S, Mozneb M, Arzt M, Hsiai TK, Sharma A. Microfluidic Organ-Chips and Stem Cell Models in the Fight Against COVID-19. Circ Res. 2023;132(10):1405-1424.
Rockwood SJ, Arzt M, Sharma A. Modeling Cardiac SARS-CoV-2 Infection with Human Pluripotent Stem Cells. Curr Cardiol Rep. 2022.
Sharma A. Modeling Congenital Heart Disease Using Pluripotent Stem Cells. Curr Cardiol Rep. 2020;22(8):55.
Mozneb M, Jenkins A, Sances S, Pohlman S, Workman MJ, West D, Ondatje B, El-Ghazawi K, Woodbury A, Garcia VJ, et al. Multi-lineage heart-chip models drug cardiotoxicity and enhances maturation of human stem cell-derived cardiovascular cells. Lab Chip. 2024.
Arzt M, Gao B, Mozneb M, Pohlman S, Cejas RB, Liu Q, Huang F, Yu C, Zhang Y, Fan X, et al. Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy. Stem Cell Reports. 2023.